Global Porokeratosis Treatment Market Size, Share, Forecast Report, 2020-2027

Global Porokeratosis Treatment Market is expected to gain prominence over the forecast period. The market is expected to register a CAGR of ~6.0% from 2018 to 2023. Various factors such as rising cases of renal transplant, improved reimbursement policies in developed countries, growing research funding, and rising competition among market players are continuously contributing to the growth of the global porokeratosis treatment market.

Multiple treatment options have been suggested for porokeratosis such as medications, cryotherapy, photodynamic therapy, and lasers. Among all the treatment approaches used for the treatment of porokeratosis, laser therapy is attracting a great deal of attention. In case of malignant lesions, excision of benign lesions is often used, but it may leave scars. So, as an alternative, the CO2 laser therapy, Nd: YAG laser, and ruby laser appear to be a promising option for the treatment of porokeratosis.

Owing to the appealing aspects about laser therapy such as no incision and no hospitalization, the adoption of laser therapy for the treatment of porokeratosis is found to be rising which further drives the growth of the market.

Despite these drivers, there are some issues associated with the porokeratosis treatment market. The high cost of laser systems, lack of skilled or trained physicians, side effects associated with drugs, and poor healthcare system in low and middle-income countries may hamper the growth of the market.
Key Players

Some of the key players in the global porokeratosis treatment market are Angiodynamics, Inc. (U.S.), Allergan (Republic of Ireland), Alma Lasers (Israel), Beiersdorf AG (Germany), Biogen (U.S.), Biolase Inc. (U.S.), Coherent, Inc. (U.S.), Coty Inc. (U.S.), Cutera (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Hologic Inc. (U.S.), IPG Photonics Corporation (U.S.), IRIDEX Corp. (U.S.), L’Oreal (France), Lumenis (U.S.), Pfizer (U.S.), PhotoMedex, Inc. (U.S.), Valeant Pharmaceuticals (Canada), and others.

Segmentation

The global porokeratosis treatment market is segmented

on the basis of type of porokeratosis, diagnosis and treatment, and end-user.

By type of porokeratosis, the market is classified as Disseminated Actinic Porokeratosis (DSAP), linear porokeratosis, porokeratosis of mantoux, Porokeratotic Eccrine Ostial and Dermal Duct Nevus (PEODDN), and punctate porokeratosis.

Based on diagnosis and treatment, the market is classified as diagnosis and treatment. The diagnosis segment is further classified as biopsy, differential diagnosis, and others. The sub-segments of differential diagnosis include squamous cell carcinoma, lichenoid keratosis, and epidermal nevus. The treatment segment is further classified as topical diclofenac, ingenol mebutate, topical vitamin D analog, 5-Fluorouracil, immunomodulators, photodynamic therapy, retinoids, cryotherapy, lasers, immunosuppressive agents, and others. The sub-segments of immunomodulators include imiquimod and resiquimod. The sub-segments of retinoids include topical retinoids and oral retinoids. The sub-segments of immunosuppressive agents include calcineurin inhibitors and others.

By end-user, the market is classified as hospitals and clinics, diagnostic centers, drug stores, research and academic institutes, and others.

Global Porokeratosis Treatment Market, by Type

• Disseminated actinic porokeratosis
• Linear porokeratosis
• Porokeratosis of Mantoux
• Porokeratotic Eccrine Ostial and Dermal Duct Nevus (PEODDN)
• Punctate porokeratosis

Global Porokeratosis Treatment Market, by Diagnosis & Treatment

• Diagnosis
• Biopsy
• Differential Diagnosis
• Squamous cell carcinoma
• Lichenoid keratosis
• Epidermal nevus
• Others
• Treatment
• Topical Diclofenac
• Ingenol Mebutate
• Topical Vitamin D analog
• 3-Fluorouracil
• Immunomodulators
• Imiquimod
• Resiquimod
• Photodynamic Therapy
• Retinoids
• Topical retinoids
• Oral retinoids
• Cryotherapy
• Lasers
• Immunosuppressive Agents
• Calcineurin inhibitors
• Others
• Others

Global Porokeratosis Treatment Market, by End-User

• Hospitals & Clinics
• Diagnostic Centers
• Drug Stores
• Research and academic institutes
• Others